Bernd Weigle Selected Research

2'- deoxythymidine- 5'- (alpha- methylphosphonyl)- beta,gamma- diphosphate

9/2005

D-TMPP: a novel androgen-regulated gene preferentially expressed in prostate and prostate cancer that is the first characterized member of an eukaryotic gene family.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bernd Weigle Research Topics

Disease

13	Neoplasms (Cancer) 01/2021 - 12/2002
7	Prostatic Neoplasms (Prostate Cancer) 05/2006 - 12/2002
4	Inflammation (Inflammations) 10/2007 - 04/2004
3	Glioma (Gliomas) 01/2007 - 01/2005
2	Breast Neoplasms (Breast Cancer) 01/2021 - 04/2004
2	Amyloid Plaque 06/2006 - 04/2003
2	Carcinoma (Carcinomatosis) 09/2005 - 09/2003
1	Asthma (Bronchial Asthma) 01/2018
1	Atherosclerotic Plaque (Atheroma) 04/2007
1	Meningioma (Meningiomas) 01/2007
1	Brain Neoplasms (Brain Tumor) 01/2007
1	Alzheimer Disease (Alzheimer's Disease) 06/2006
1	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2006
1	Melanoma (Melanoma, Malignant) 05/2005
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2005
1	Neoplasm Metastasis (Metastasis) 02/2005
1	Glioblastoma (Glioblastoma Multiforme) 01/2005
1	Carcinogenesis 01/2005
1	Neuroblastoma 03/2002

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 06/2007 - 09/2003
6	AntigensIBA 07/2007 - 12/2002
4	Messenger RNA (mRNA)IBA 02/2005 - 07/2003
3	Inhibitor of Apoptosis ProteinsIBA 06/2007 - 01/2003
3	SurvivinIBA 06/2007 - 01/2003
3	EpitopesIBA 04/2007 - 12/2002
3	Peptides (Polypeptides)IBA 01/2007 - 12/2002
2	Polysaccharides (Glycans)IBA 01/2021 - 03/2002
2	Receptor for Advanced Glycation End ProductsIBA 04/2007 - 02/2005
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2007 - 09/2003
2	SOXC Transcription FactorsIBA 01/2007 - 01/2005
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 05/2006 - 09/2004
2	Complementary DNA (cDNA)IBA 09/2004 - 04/2004
2	HLA-A*02:01 antigenIBA 09/2003 - 12/2002
1	LigandsIBA 01/2021
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Sialic Acid Binding Immunoglobulin-like LectinsIBA 01/2021
1	SteroidsIBA 01/2018
1	Hypochlorous Acid (Hypochlorite)IBA 10/2007
1	Oxidants (Oxidizing Agents)IBA 10/2007
1	oxidized low density lipoproteinIBA 10/2007
1	LDL Lipoproteins (beta Lipoproteins)IBA 10/2007
1	AlbuminsIBA 04/2007
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2007
1	AntibodiesIBA 01/2007
1	Immunoglobulin G (IgG)IBA 01/2007
1	AutoantibodiesIBA 01/2007
1	Advanced Glycation End ProductsIBA 06/2006
1	Neoplasm Antigens (Tumor Antigens)IBA 05/2006
1	2'- deoxythymidine- 5'- (alpha- methylphosphonyl)- beta,gamma- diphosphateIBA 09/2005
1	AndrogensIBA 09/2005
1	Monophenol Monooxygenase (Tyrosinase)IBA 05/2005
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2005
1	HMGB1 Protein (HMG1)IBA 02/2005
1	S100 Proteins (S 100 Protein)IBA 04/2004
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 04/2004
1	Amino Acids FDA Link 04/2004
1	Tumor Biomarkers (Tumor Markers)IBA 07/2003
1	Amyloid (Amyloid Fibrils)IBA 04/2003

Therapy/Procedure

5	Therapeutics 06/2007 - 12/2002
4	Immunotherapy 01/2007 - 12/2002